Karoline Horisberger

Author

Also Known As

G István, Horisberger K, Jens Forberger, K Horisberger, K. E. Horisberger, K. Horisberger, Karoline Horisberger, L S Lino-Silva, Nir Horesh

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Heidelberg University University Hospital Heidelberg University Medical Centre Mannheim University Hospital of Zurich German Cancer Research Center

About

Karoline Horisberger is an author at Heidelberg University specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	508
2	Health Sciences	7	7	335
3	Cell Biology	2	2	43
4	Engineering	1	1	35
5	Anatomy	1	1	11

Karoline Horisberger

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Cetuximab in Combination With Capecitabine, Irinotecan, and Radiotherapy for Patients With Locally Advanced Rectal Cancer: Results of a Phase II MARGIT Trial Karoline Horisberger, Anne Treschl, Sabine Mai, International Journal of Radiation OncologyBiologyPhysics Radiation TherapyGastrointestinal OncologyMedicineCancer TreatmentOncology	2009	108
A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer Frank Willeke, Karoline Horisberger, Uta Kraus-Tiefenbacher, British Journal of Cancer	2007	103
Artificial intelligence for detection of microsatellite instability in colorectal cancer—a multicentric analysis of a pre-screening tool for clinical application Amelie Echle, Narmin Ghaffari Laleh, Philip Quirke, ESMO Open	2022	101
Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer Ralf‐Dieter Hofheinz, Karoline Horisberger, Christoph M. Woernle, International Journal of Radiation OncologyBiologyPhysics Surgical OncologyRadiation TherapyNeoadjuvant TherapyWeekly IrinotecanMedicine	2006	94
Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database Mev Dominguez–Valentin, Saskia Haupt, Toni T. Seppälä, EClinicalMedicine	2023	91
Local excision of early rectal cancer: is transanal endoscopic microsurgery an alternative to radical surgery? P. Palma, Karoline Horisberger, A. Joós, Revista Española de Enfermedades Digestivas	2009	71
KRAS and BRAF Mutations and PTEN Expression Do Not Predict Efficacy of Cetuximab-Based Chemoradiotherapy in Locally Advanced Rectal Cancer Philipp Erben, Philipp Ströbel, Karoline Horisberger, International Journal of Radiation OncologyBiologyPhysics Radiation TherapyGastrointestinal OncologyPten Expression DoBraf MutationsMedicine	2010	54
Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium Pål Møller, Toni T. Seppälä, James G. Dowty, Hereditary Cancer in Clinical Practice	2022	52
Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy Juliana Schwaab, Karoline Horisberger, Philipp Ströbel, BMC Cancer PathologyDisease-free SurvivalCancer BiologyTumor BiologyTumour Regression	2011	43
Tumor response to neoadjuvant chemoradiation in rectal cancer: predictor for surgical morbidity? Karoline Horisberger, R. D. Hofheinz, P. Palma, International Journal of Colorectal Disease Tumor ResponseNeoadjuvant ChemoradiationSurgical OncologyRadiation TherapyGastrointestinal Oncology	2007	41

Page 1